Please assess the completion status of the following clinical trial:

Trial Title: Outpatient Neutropenic Diet Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Newly diagnosed patients with acute myelogenous leukemia (AML), acute lymphocytic leukemia ( ALL), or myelodysplastic syndrome (MDS) receiving induction chemotherapy or AML, ALL or MDS patients who are in remission receiving consolidation chemotherapy.~2. Patients who will be receiving myelosuppressive chemotherapy for their disease.~3. Patients who will be able to stay in the Houston area for at least 4 weeks.~4. Patients who can speak either English or Spanish.~Exclusion Criteria:~1. Patients who present with an active infection such as pneumonia, bacteremia, urine, c. difficile or cellulitis infection.~2. Patients who are unable to understand the diet questionnaire which will be written in either English or Spanish.~3. Patients who are admitted to the protective environment.~4. Patients who are younger than age 18 will not be entered in the study.~5. Pregnant patients.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Raw Group (Type: OTHER): Participants will eat cooked food and the addition of raw fruits and vegetables.
- Cooked Group (Type: OTHER): Participants will eat only cooked foods.

Based on this trial design, predict the completion outcome and termination type (if applicable).